Drug Search Results
More Filters [+]

Nesbuvir

Alternative Names: nesbuvir, hcv-796, hcv796, hcv 796
Latest Update: 2013-02-11
Latest Update Note: Clinical Trial Update

Product Description

Mechanisms of Action: HCV-NS5B Inhibitor,NN Inhibitor

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Oral

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: Pfizer
Company Location: NEW YORK NY 10017
Company CEO: Albert Bourla
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Nesbuvir

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 2: Hepatitis A|Hepatitis C

Phase 1: Healthy Volunteers|Hepatic Insufficiency|Hepatitis C|Liver Failure

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

3173A1-200

P2

Completed

Hepatitis A|Hepatitis C

2008-07-01

3173A1-105

P1

Completed

Liver Failure|Hepatitis C|Hepatic Insufficiency

2007-10-01

3173A1-1120

P1

Completed

Healthy Volunteers

2007-08-01

3173A1-112

P1

Completed

Healthy Volunteers

2007-06-01

Recent News Events

Date

Type

Title